@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix nalt: <https://lod.nal.usda.gov/nalt/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix ns0: <https://lod.nal.usda.gov/naltv#> .

<https://lod.nal.usda.gov/naltv#marc001> rdfs:label "Field 001 in MARC Authority Format"@en .
nalt:2520_def
  a <https://lod.nal.usda.gov/naltv#Definition> ;
  rdf:value "Drogas que mimetizan los efectos de la actividad del sistema nervioso parasimpático. Aquí se incluyen las drogas que estimulan directamente a los receptores muscarínicos y las drogas que potencian la actividad colinérgica, usualmente al disminuir la eliminación de acetilcolina."@es, "Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (cholinesterase inhibitors)."@en ;
  dc:source "Medical Subject Headings 2012" .

<https://lod.nal.usda.gov/nalt>
  a skos:ConceptScheme ;
  rdfs:label "NALT Full"@en .

<https://lod.nal.usda.gov/naltv#Chemical>
  a owl:Class ;
  rdfs:label "Chemical"@en .

nalt:2520
  a skos:Concept, <https://lod.nal.usda.gov/naltv#Chemical> ;
  dc:created "2006-01-19"^^xsd:date ;
  dc:modified "2012-11-30"^^xsd:date ;
  skos:altLabel "parasympathomimetic drugs"@en, "parasympathomimetic agents"@en, "parasympathomimetic effect"@en ;
  skos:broader nalt:286 ;
  skos:closeMatch <http://id.loc.gov/authorities/subjects/sh85097931> ;
  skos:definition nalt:2520_def ;
  skos:inScheme <https://lod.nal.usda.gov/nalt> ;
  skos:narrower nalt:2518, nalt:25591, nalt:22186, nalt:22152, nalt:16910, nalt:46949 ;
  skos:prefLabel "parasympathomimetics"@en, "parasimpaticomiméticos"@es ;
  skos:related nalt:22191 ;
  ns0:marc001 "27175" .

nalt:46949
  a ns0:Chemical, skos:Concept ;
  skos:broader nalt:2520 ;
  skos:prefLabel "pilocarpina"@es, "pilocarpine"@en .

nalt:16910
  a ns0:Chemical, skos:Concept ;
  skos:broader nalt:2520 ;
  skos:prefLabel "bethanechol"@en, "betanecol"@es .

nalt:22152
  a ns0:Chemical, skos:Concept ;
  skos:broader nalt:2520 ;
  skos:prefLabel "carbachol"@es, "carbachol"@en .

nalt:22186
  a ns0:Chemical, skos:Concept ;
  skos:broader nalt:2520 ;
  skos:prefLabel "fisostigmina"@es, "physostigmine"@en .

nalt:25591
  a ns0:Chemical, skos:Concept ;
  skos:broader nalt:2520 ;
  skos:prefLabel "neostigmina"@es, "neostigmine"@en .

nalt:2518
  a ns0:Chemical, skos:Concept ;
  skos:broader nalt:2520 ;
  skos:prefLabel "acetilcolina"@es, "acetylcholine"@en .

nalt:22191
  a ns0:Chemical, skos:Concept ;
  skos:prefLabel "inhibidores de la colinesterasa"@es, "cholinesterase inhibitors"@en ;
  skos:related nalt:2520 .

nalt:286
  a ns0:Chemical, skos:Concept ;
  skos:narrower nalt:2520 ;
  skos:prefLabel "medicamentos"@es, "drugs"@en .